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We have been very interested with the reading of the article by
Roehmel et al. “Hypersensitivity to antibiotics in patients with
cystic fibrosis”, published in the Journal of Cystic Fibrosis [1]. In
this study based on a review of medical records and interviews of
the patients, the authors conclude that hypersensitivity (HS)
reactions to antibiotics affect 60% of the patients, with a rate of
5.75% antibiotic courses, leading to changes of therapy in 65% of
the cases. Most frequent reactions were reported with beta-lactams,
cefepime and piperacillin/tazobactam especially (10% of treatment
courses with these antibiotics), occurred within 4 days of the start
of treatment, and were dependent on cumulative drug exposure.
These results are consistent with those of other studies
showing that anti-infectious drug HS, to beta-lactams especially,
is suspected in 29–62% (mean = 30%) of cystic fibrosis (CF)
patients (Rev. in: [2,3]). These results strongly suggested that the
high prevalence of (suspected) allergy to anti-infectious drugs in
patients with CF resulted from their frequent exposition to these
drugs. Indeed, it has been shown that repeated administration
of antigens/allergens, especially by the IV route, was highly
immunogenic/allergenic [4].
However, in these studies, diagnosis of betalactam HS was
solely based on clinical history, probably leading to over-diagnosis.
More recent studies based on skin and challenge tests have shown
that only 0–4% of CF patients were truly allergic to beta-lactams
[2,3]. In the study by Caimmi et al. [2], 23/171 (13.45%) CF
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of these patients (30.4%), representing 4% of the CF patients, were
diagnosed allergic to beta-lactams. In the recent study by Matar et
al. [3], performed in a highly specialized pediatric center for CF
and exploration of drug hypersensitivities, only 1.14% of the CF
children reported highly suggestive reactions and needed to be
explored for suspected beta-lactam HS by means of skin (pricks,
ID and patch-tests) and challenge tests. In the other children, with
no or less suggestive reactions such as non-immediate benign
urticaria or non-urticarial rashes and isolated non-immediate fever,
skin tests were not performed and diagnosis was often ruled-out
directly on the tolerance of challenge tests performed with the
suspected beta-lactams. Although 47.3% of the children explored
by means of skin and challenge tests were diagnosed allergic to
beta-lactams, all of whom reporting severe and/or immediate/very
early reactions, beta-lactam HS was diagnosed in only 0.7% of the
children with CF.
Thus:(1) although it has been claimed that frequent exposure to
drugs may lead to sensitization and allergic hypersensi-
tivity (Rev. in: [2,3]), repeated or chronic exposure
to antigens/allergens may also lead to immunological
tolerance, depending on the genetic background, the age
and nutritional status of the subjects, the conditions
of allergen exposure, and other environmental factors [4];
(2) as shown in non-CF patients [5,6], most allergic-like
reactions to antibiotics, beta-lactams especially, more likely
result from the infectious diseases (viral infections) for
which the antibiotics have been prescribed and/or from
microbial death than from drug HS;by Elsevier B.V. All rights reserved.
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diagnosis should not be based solely on a (more or less)
clinical history of the patients, but on a careful analysis of
their clinical history, skin tests (if feasible and validated),
possibly in vitro tests, and challenge tests with the sus-
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